TrialAdvances in therapy2021

Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies.

Gavin Giovannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.